KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $31.7 billion.

  • AbbVie's Other Non-Current Liabilities fell 416.58% to $31.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 billion, marking a year-over-year decrease of 416.58%. This contributed to the annual value of $30.1 billion for FY2024, which is 679.93% down from last year.
  • Per AbbVie's latest filing, its Other Non-Current Liabilities stood at $31.7 billion for Q3 2025, which was down 416.58% from $32.0 billion recorded in Q2 2025.
  • AbbVie's 5-year Other Non-Current Liabilities high stood at $33.0 billion for Q3 2024, and its period low was $26.9 billion during Q1 2021.
  • In the last 5 years, AbbVie's Other Non-Current Liabilities had a median value of $31.2 billion in 2025 and averaged $30.8 billion.
  • Per our database at Business Quant, AbbVie's Other Non-Current Liabilities skyrocketed by 5008.94% in 2021 and then plummeted by 679.93% in 2024.
  • AbbVie's Other Non-Current Liabilities (Quarter) stood at $28.7 billion in 2021, then grew by 6.81% to $30.7 billion in 2022, then grew by 5.45% to $32.3 billion in 2023, then decreased by 6.8% to $30.1 billion in 2024, then increased by 5.06% to $31.7 billion in 2025.
  • Its last three reported values are $31.7 billion in Q3 2025, $32.0 billion for Q2 2025, and $31.2 billion during Q1 2025.